Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M121,911Revenue $M41,633Net Margin (%)12.3Z-Score0
Enterprise Value $M121,911EPS $1.7Operating Margin %17.3F-Score0
P/E(ttm))24.1Cash Flow Per Share $0Pre-tax Margin (%)16.2Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %3.8Quick Ratio0Cash flow > EarningsN
Price/Sales3.05-y EBITDA Growth Rate %-2.0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %17.6ROA % (ttm)8.7Higher Current Ratio y-yN
Dividend Yield %4.1Insider Buy (3m)0ROE % (ttm)15.0Less Shares Outstanding y-yN
Payout Ratio %90.0Shares Outstanding M2,642ROI % (ttm)4.2Gross Margin Increase y-yN

Gurus Latest Trades with SNY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNYBill Nygren 2014-09-30 Add0.27%$50.89 - $57.29
($53.73)
$ 46.15-14%Add 14.55%5,670,000
SNYPRIMECAP Management 2014-09-30 Add0.05%$50.89 - $57.29
($53.73)
$ 46.15-14%Add 29.21%3,891,356
SNYJean-Marie Eveillard 2014-09-30 Reduce-0.07%$50.89 - $57.29
($53.73)
$ 46.15-14%Reduce -94.39%34,157
SNYBill Nygren 2014-06-30 Add0.9%$51.23 - $54.54
($53.08)
$ 46.15-13%Add 90.38%4,950,000
SNYPRIMECAP Management 2014-06-30 Add0.03%$51.23 - $54.54
($53.08)
$ 46.15-13%Add 21.59%3,011,646
SNYNWQ Managers 2014-06-30 Reduce-1.31%$51.23 - $54.54
($53.08)
$ 46.15-13%Reduce -52.34%2,602,503
SNYScott Black 2014-06-30 Reduce-0.39%$51.23 - $54.54
($53.08)
$ 46.15-13%Reduce -27.57%178,985
SNYJohn Hussman 2014-06-30 Sold Out -0.09%$51.23 - $54.54
($53.08)
$ 46.15-13%Sold Out0
SNYScott Black 2014-03-31 Buy 1.4%$47.77 - $53.63
($50.64)
$ 46.15-9%New holding, 247100 sh.247,100
SNYBill Nygren 2014-03-31 Buy 1.1%$47.77 - $53.63
($50.68)
$ 46.15-9%New holding, 2600000 sh.2,600,000
SNYHOTCHKIS & WILEY 2014-03-31 Add0.75%$47.77 - $53.63
($50.68)
$ 46.15-9%Add 65.83%9,804,594
SNYJames Barrow 2014-03-31 Add0.39%$47.77 - $53.63
($50.68)
$ 46.15-9%Add 22.72%27,790,116
SNYNWQ Managers 2014-03-31 Reduce-0.17%$47.77 - $53.63
($50.68)
$ 46.15-9%Reduce -6.39%5,460,055
SNYHOTCHKIS & WILEY 2013-12-31 Add0.27%$48.75 - $54
($51.57)
$ 46.15-10%Add 23.53%5,912,375
SNYCharles Brandes 2013-12-31 Add0.2%$48.75 - $54
($51.57)
$ 46.15-10%Add 18.29%2,013,300
SNYNWQ Managers 2013-12-31 Add0.19%$48.75 - $54
($51.57)
$ 46.15-10%Add 7.52%5,832,760
SNYMario Gabelli 2013-12-31 Reduce$48.75 - $54
($51.57)
$ 46.15-10%Reduce -24.37%4,500
SNYJames Barrow 2013-09-30 Add1.29%$47.64 - $53.24
($50.87)
$ 46.15-9%Add 312.86%21,466,988
SNYHOTCHKIS & WILEY 2013-09-30 Add0.26%$47.64 - $53.24
($50.87)
$ 46.15-9%Add 31.71%4,786,334
SNYMario Gabelli 2013-09-30 Add$47.64 - $53.24
($50.87)
$ 46.15-9%Add 32.22%5,950
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SNY PRIMECAP Management 2014-09-303,891,3560.150.23+29.21%
SNY Bill Nygren 2014-09-305,670,0000.212.1+14.55%
SNY Charles Brandes 2014-09-302,248,9020.091.7+3.05%
SNY Mario Gabelli 2014-09-304,58000+1.78%
SNY HOTCHKIS & WILEY 2014-09-309,895,5210.372+1.26%
SNY Ken Fisher 2014-09-3013,145,6470.51.6+0.51%
SNY Warren Buffett 2014-09-303,905,8750.150.2
SNY Scott Black 2014-09-30178,4100.011.4-0.32%
SNY Dodge & Cox 2014-09-3043,267,0041.642.3-0.65%
SNY James Barrow 2014-09-3028,293,7231.072.2-0.82%
SNY NWQ Managers 2014-09-302,409,0400.091.5-7.43%
SNY Third Avenue Management 2014-09-3012,30600.02-8.18%
SNY Jean-Marie Eveillard 2014-09-3034,15700-94.39%
SNY Bill Nygren 2014-06-304,950,0000.191.9+90.38%
Premium Most recent portfolio changes are included for Premium Members only!


SNY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2014-03-25Buy344,448$66.88-30.7view
Sanofi10% Owner 2014-02-04Buy1,303,780$7.67504.3view

Press Releases about SNY :

Quarterly/Annual Reports about SNY:

    News about SNY:

    Articles On GuruFocus.com
    Guru Stocks at 52-Week Lows: HSBC, SNY, WBK, DCM, BBVA Dec 23 2014 
    The Top 5 European Stocks Held During Q3 Nov 25 2014 
    Guru Stocks at 52-Week Lows: IBM, SNY, SAN, RIO, E Nov 09 2014 
    Guru Stocks at 52-Week Lows: IBM, BBL, SNY, SAN, RIO Nov 04 2014 
    Zoetis Will Benefit from Industry Trends Oct 07 2014 
    International Securities For A Diversified Income Portfolio Sep 23 2014 
    Widely Held Guru Stocks Trading In Europe Sep 22 2014 
    Why Investing Internationally Can Help Your Portfolio Sep 12 2014 
    The MS Global Franchise Fund's Top Five Stocks Sep 10 2014 
    Guru Stocks at 52-Week Lows: CHL, TM, SNY, NVO, TSM Sep 02 2014 

    More From Other Websites
    Quick Update: New Hires, Recent Panel Discussion Emphasize Confluence Of Pharma And Big Data Dec 24 2014
    Lieff Cabraser Announces Class Action Litigation Against Sanofi – SNY Dec 22 2014
    EQUITY ALERT: Rosen Law Firm Reminds Sanofi Investors of Important Class Action Deadline - SNY Dec 21 2014
    SANOFI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds... Dec 20 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Sanofi... Dec 19 2014
    5 Big Stocks to Trade After the Fed's Rate News: Microsoft, Goldman and More Dec 18 2014
    Merial acquires two major equine health products from Bayer Dec 17 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Dec 16 2014
    Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations... Dec 15 2014
    Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for... Dec 12 2014
    The Big Business of Selling Prescription-Drug Records Dec 11 2014
    SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sanofi SA and... Dec 11 2014
    Livestock products lead Zoetis’ 3Q14 revenue growth Dec 11 2014
    Robbins Arroyo LLP: Sanofi (SNY) Misled Shareholders According to a Recently Filed Class Action Dec 10 2014
    Must-know trends that drive Zoetis’ growth Dec 10 2014
    Toast The New Year With 5 Undervalued Dividend Stocks Dec 10 2014
    Will Sanofi (SNY) Stock Advance Today on Diversification, Acquisitions Strategy? Dec 10 2014
    Pershing Square takes 8.5% stake in Zoetis Dec 10 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Dec 09 2014
    Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO Dec 09 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK